Pacific Bio (PACB) Misses Q1 EPS by 3c

Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $24.9 million versus the consensus estimate of $24.61 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Barclays says AI trade is maturing, favors greater diversification
• Nucor projects Q3 2026 earnings above prior year, below estimates